(Q38075516)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

review article

1 reference

title

SOCS and diabetes--ups and downs of a turbulent relationship (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Bogusław Okopień

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2

Krzysztof Łabuzek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

Dariusz Suchy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Michał Kozłowski

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

18 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

Cell Biochemistry & Function

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

181-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

Genetics, pathogenesis and clinical interventions in type 1 diabetes

22 February 2020

cites work

1 reference

Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines

21 January 2018

1 reference

SOCS proteins causing trouble in insulin action

21 January 2018

1 reference

Obesity and insulin resistance

21 January 2018

1 reference

SOCS: role in inflammation, allergy and homeostasis

21 January 2018

1 reference

Suppressors of cytokine signalling: SOCS.

21 January 2018

1 reference

The many faces of the SOCS box.

21 January 2018

1 reference

High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells

21 January 2018

1 reference

Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus

21 January 2018

1 reference

SOCS-1 protein prevents Janus Kinase/STAT-dependent inhibition of beta cell insulin gene transcription and secretion in response to interferon-gamma

21 January 2018

1 reference

Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction.

21 January 2018

1 reference

Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death

21 January 2018

1 reference

Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.

21 January 2018

1 reference

SOCS-1 protects from virally-induced CD8 T cell mediated type 1 diabetes.

21 January 2018

1 reference

Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy β-Cells via the Perforin and Fas Pathways

21 January 2018

1 reference

Perforin and Fas induced by IFNγ and TNFα mediate beta cell death by OT-I CTL

21 January 2018

1 reference

Target cell defense prevents the development of diabetes after viral infection.

21 January 2018

1 reference

Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells

21 January 2018

1 reference

Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity

21 January 2018

1 reference

Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection

21 January 2018

1 reference

IL-1beta-induced chemokine and Fas expression are inhibited by suppressor of cytokine signalling-3 in insulin-producing cells

21 January 2018

1 reference

Suppression of SOCS3 expression in the pancreatic beta-cell leads to resistance to type 1 diabetes.

21 January 2018

1 reference

Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.

21 January 2018

1 reference

Regulation of pancreatic beta-cell mass and proliferation by SOCS-3.

21 January 2018

1 reference

The potential role of SOCS-3 in the interleukin-1beta-induced desensitization of insulin signaling in pancreatic beta-cells.

21 January 2018

1 reference

Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells

21 January 2018

1 reference

No non-redundant function of suppressor of cytokine signaling 2 in insulin producing β-cells

21 January 2018

1 reference

The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion.

21 January 2018

1 reference

Suppressor of cytokine signaling 1 inhibits apoptosis of islet grafts through caspase 3 and apoptosis-inducing factor pathways in rats

21 January 2018

1 reference

Overexpression of suppressor of cytokine signaling 1 in islet grafts results in anti-apoptotic effects and prolongs graft survival

21 January 2018

1 reference

Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.

21 January 2018

1 reference

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

21 January 2018

1 reference

Regulation of insulin receptor function

21 January 2018

1 reference

SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2

21 January 2018

1 reference

Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng

21 January 2018

1 reference

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

21 January 2018

1 reference

Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome

21 January 2018

1 reference

Amyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway

21 January 2018

1 reference

Socs1 deficiency enhances hepatic insulin signaling.

21 January 2018

1 reference

Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance.

21 January 2018

1 reference

Functional SOCS1 polymorphisms are associated with variation in obesity in whites.

21 January 2018

1 reference

SOCS-1 deficiency does not prevent diet-induced insulin resistance

21 January 2018

1 reference

Lack of association between the tagging SNP A+930-->G of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations

21 January 2018

1 reference

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

21 January 2018

1 reference

Control of fatty acid metabolism by leptin in L6 rat myoblasts is regulated by hyperinsulinemia.

21 January 2018

1 reference

Interleukin-6 and insulin resistance

21 January 2018

1 reference

Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes

21 January 2018

1 reference

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

21 January 2018

1 reference

Genetic ablation of cGMP-dependent protein kinase type I causes liver inflammation and fasting hyperglycemia

21 January 2018

1 reference

Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats

21 January 2018

1 reference

Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients

21 January 2018

1 reference

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

21 January 2018

1 reference

Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion

21 January 2018

1 reference

Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis

21 January 2018

1 reference

Combined neural inactivation of suppressor of cytokine signaling-3 and protein-tyrosine phosphatase-1B reveals additive, synergistic, and factor-specific roles in the regulation of body energy balance

21 January 2018

1 reference

Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance

21 January 2018

1 reference

Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3

21 January 2018

1 reference

Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis

21 January 2018

1 reference

Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.

21 January 2018

1 reference

Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor

21 January 2018

1 reference

The crosstalk between insulin and renin-angiotensin-aldosterone signaling systems and its effect on glucose metabolism and diabetes prevention.

21 January 2018

1 reference

The multi-faceted cross-talk between the insulin and angiotensin II signaling systems.

21 January 2018

1 reference

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance

21 January 2018

1 reference

Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling

21 January 2018

1 reference

The dual function of hepatic SOCS3 in insulin resistance in vivo.

21 January 2018

1 reference

Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and Type 2 diabetes patients

21 January 2018

1 reference

Association of single-nucleotide polymorphisms in the suppressor of cytokine signaling 2 (SOCS2) gene with type 2 diabetes in the Japanese

21 January 2018

1 reference

Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism.

21 January 2018

1 reference

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

21 January 2018

1 reference

Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans

21 January 2018

1 reference

TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis

21 January 2018

1 reference

Suppressors of cytokine-signaling proteins induce insulin resistance in the retina and promote survival of retinal cells

21 January 2018

1 reference

Impairment of insulin receptor signal transduction in placentas of intra-uterine growth-restricted newborns and its relationship with fetal growth.

21 January 2018

1 reference

Suppressors of cytokine signaling abrogate diabetic nephropathy

21 January 2018

1 reference

Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy

21 January 2018

1 reference

Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells

21 January 2018

1 reference

Nutrient stress activates inflammation and reduces glucose metabolism by suppressing AMP-activated protein kinase in the heart

21 January 2018

1 reference

Pioglitazone for diabetes prevention in impaired glucose tolerance.

21 January 2018

1 reference

Hepatic inflammation and insulin resistance in pre-diabetes - further evidence for the beneficial actions of PPAR-gamma agonists and a role for SOCS-3 modulation

21 January 2018

1 reference

Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation

21 January 2018

1 reference

Pioglitazone promotes survival and prevents hepatic regeneration failure after partial hepatectomy in obese and diabetic KK-A(y) mice

21 January 2018

1 reference

Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

21 January 2018

1 reference

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

21 January 2018

1 reference

Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

21 January 2018

1 reference

Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

21 January 2018

1 reference

Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.

21 January 2018

1 reference

Exenatide exerts a potent antiinflammatory effect

21 January 2018

1 reference

The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice.

21 January 2018

1 reference

Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages

21 January 2018

1 reference

Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation

21 January 2018

1 reference

Transcriptional regulation of cytokines and oxidative stress by gallic acid in human THP-1 monocytes

21 January 2018

1 reference

Pyrrolidine Dithiocarbamate Inhibits Interleukin-6 Signaling through Impaired STAT3 Activation and Association with Transcriptional Coactivators in Hepatocytes

21 January 2018

1 reference

Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes

21 January 2018

1 reference

JANEX-1, a JAK3 inhibitor, protects pancreatic islets from cytokine toxicity through downregulation of NF-kappaB activation and the JAK/STAT pathway

21 January 2018

1 reference

Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

21 January 2018

1 reference

HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus

21 January 2018

1 reference

Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity

21 January 2018

1 reference

SOCS3 inhibits insulin signaling in porcine primary adipocytes

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1007/S11010-010-0558-7

Identifiers

DOI

10.1002/CBF.2940

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23335325%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference